Literature DB >> 31154518

Development of sodium glucose co-transporter 2 (SGLT2) inhibitors with novel structure by molecular docking and dynamics simulation.

Ruirui Feng1, Lili Dong1, Leng Wang1, Yefei Xu1, Huizhe Lu2, Jianjun Zhang3.   

Abstract

In this study, molecular docking studies were carried out to explore the binding interactions of sodium glucose co-transporter 2 (SGLT2) with its inhibitors. A correlation between the docking scores and the experimental bioactivity was observed (R2 = 0.8368, N = 24). The new inhibitors were designed using the 3D quantitative structure activity relationship (3D-QSAR) method, and the activities were predicted by the docking method. In order to understand the structure-activity correlation of compound 1 m (the highest score of docking) and compound 1 t (the lowest score), we carried out a combined molecular dynamics simulation and MM-GBSA method. It was found that, in the system of SGLT2-1 m, the interaction between Gln271 and Val272 exhibited significant effects, which were absent in the SGLT2-1 t system. This study is expected to shed light on the mechanism of action of compound 1 m, leading to development of active drug candidates targeting SGLT2.

Entities:  

Keywords:  3D-QSAR; Decomposition free energy calculation; Free energy calculation; Molecular docking; Molecular dynamics simulation; SGLT2

Mesh:

Substances:

Year:  2019        PMID: 31154518     DOI: 10.1007/s00894-019-4067-7

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  3 in total

1.  Investigation of Hypoglycemic Peptides Derived from Conserved Regions of adMc1 to Reveal Their Antidiabetic Activities.

Authors:  Hafiza Salaha Mahrosh; Rizwan Mehmood; Shazia Anwer Bukhari; Gulnaz Afzal; Rawaba Arif
Journal:  Biomed Res Int       Date:  2021-03-08       Impact factor: 3.411

Review 2.  Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.

Authors:  Kai-Jung Lin; Tzu-Jou Wang; Shang-Der Chen; Kai-Lieh Lin; Chia-Wei Liou; Min-Yu Lan; Yao-Chung Chuang; Jiin-Haur Chuang; Pei-Wen Wang; Jong-Jer Lee; Feng-Sheng Wang; Hung-Yu Lin; Tsu-Kung Lin
Journal:  Antioxidants (Basel)       Date:  2021-12-02

3.  Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia.

Authors:  Rawaba Arif; Sajjad Ahmad; Ghulam Mustafa; Hafiza Salaha Mahrosh; Muhammad Ali; Muhammad Tahir Ul Qamar; Hafiza Rabia Dar
Journal:  Biomed Res Int       Date:  2021-09-17       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.